Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease
Background: Loss of CD95 expression in tumour cells occurs frequently in colon carcinoma and may be associated with disease progression. On the other hand, neo-expression of CD95L in tumour cells may contribute to immune evasion. Aims: We aimed at further exploring the functional role and prognostic...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Copyright 2005 by Gut
2005
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1774512/ https://ncbi.nlm.nih.gov/pubmed/15831912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2004.052696 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|